A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer
一项单臂 Ib 期研究,旨在评估个性化肽脉冲树突状细胞多靶点细胞毒性 T 淋巴细胞免疫疗法联合托瑞普利单抗作为晚期非小细胞肺癌二线疗法的疗效。
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-026-04338-7
Zhang, Weihong; Qin, Jing; Luo, Jing; Xiong, Yanjuan; Yang, Fan; Li, Bin; Shen, Meng; Geng, Huizhen; Li, Zibo; Tian, Xiao; Li, Shuzhan; Li, Runmei; Wang, Yang; Zhang, Xinwei; Ren, Xiubao; Sun, Qian; Zhou, Li; Liu, Liang
肺癌
肿瘤
肿瘤免疫
树突状细胞
细胞生物学
毒理研究
树突状细胞
免疫/内分泌